Skip to main content
. 2016 Jan 28;7(15):20507–20519. doi: 10.18632/oncotarget.7050

Table 1. Main characteristics of included studies in the meta-analysis.

Author Year Country Duration Months Patients Number Detection Methods
Arima C[18] 2014 Japan 91 126 cDNA Microarray
Cui ZS[19] 2014 China 5 30 Elisa
He DP[20] 2014 China 24 48 RT-PCR, IHC
He JJ[21] 2012 China 40 65 IHC
Hou J[22] 2010 Netherlands NR* 82 cDNA Microarray
Karlsson A[23] 2014 Sweden NR* 121 cDNA Microarray
Kastner S 2012 Austria NR* 16 cDNA Microarray
Lo FY[24] 2012 Taiwan, China NR* 21 cDNA Microarray
Naumnik W[25] 2009 Poland NR* 40 Elisa
Rousseaux S[26] 2013 France NR* 272 cDNA Microarray
Shang GH[27] 2009 China 42 145 Elisa
Shen X[28] 2009 China 24 63 RT-PCR, WB
Su WM[29] 2012 China 24 69 IHC
Wang FL[30] 2009 China 7 53 IHC
Wang JY[31] 2014 China 3 30 Elisa, IHC
Wang Y[32] 2014 China 12 30 RT-PCR, Elisa
Xu SB[33] 2009 China 48 52 IHC
Yang XM[34] 2013 China 24 64 RT-PCR
Zhang SD[35] 2011 China 24 95 IHC
Zhang X[36] 2013 China 36 106 IHC
*

NR: not reporting.